Literature DB >> 10925742

Non-inflammatory enthesopathies of the spine: a diagnostic approach.

B Mazières1, J Rovensky.   

Abstract

Ankylosing vertebral hyperostosis, or hyperostotic disease, is an ossification of the entheses, the regions of insertion of tendons, ligaments or joint capsules into the bone. These ossifications create intervertebral bridges (ossifications of the common anterior, lateral and posterior intervertebral ligaments as well as of the ligamentum flavum), which are responsible for the potential signs of the disease: back and neck pain and stiffness, spinal cord compression at the cervical level and lumbar canal stenosis at the lumbar level. The bony epiphyses are the sites of bony appositions, or enthesophytes, which may compromise joint mobility and increase the risk of secondary osteoarthritis, causing hip and knee disorders in particular. These degenerative joint diseases may eventually necessitate total replacement. In this case, the risk of re-ossification around the prosthesis must be averted by the immediate postoperative prescription of anti-inflammatory medication for 1-2 weeks.

Entities:  

Mesh:

Year:  2000        PMID: 10925742     DOI: 10.1053/berh.1999.0062

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  3 in total

1.  Presentation and treatment of anterior cervical hyperostosis.

Authors:  M C Quaye; J L Fowler; J T Griffiths
Journal:  Ann R Coll Surg Engl       Date:  2015-08-14       Impact factor: 1.891

Review 2.  Where tendons and ligaments meet bone: attachment sites ('entheses') in relation to exercise and/or mechanical load.

Authors:  M Benjamin; H Toumi; J R Ralphs; G Bydder; T M Best; S Milz
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

3.  Diffuse idiopathic skeletal hyperostosis (DISH) of the elbow: a controlled radiological study.

Authors:  Christine Beyeler; Sergio R Thomann; Niklaus J Gerber; Christine Kunze; Daniel Aeberli
Journal:  BMC Musculoskelet Disord       Date:  2015-05-16       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.